Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01120977|
Recruitment Status : Completed
First Posted : May 11, 2010
Last Update Posted : November 7, 2011
|Condition or disease|
|Growth Hormone Deficiency|
The treatment of Growth Hormone deficiency (GHD) patients with GH, has since 1994 been approved in several countries. The approval is based on studies that show positive effect on body composition, physiology, lipid profile, bone density and life quality. One often observed side effect is fluid retention; this effect is dose dependent and temporary. The symptoms are swelling of soft tissue and joint stiffness.
By comparing the body bioelectric impedance (BIA) with an Arm Muscle Area (AMA) measurement, it is possible to determine the hydrations status of a person. This measurement is a simple and non invasive method to evaluate the GH dosages applied in the treatment of GHD persons.
The objective of this study is to create BIA/AMA reference data of healthy persons of both genders in the age 20-70 years.
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study|
|Study Start Date :||May 2010|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||August 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01120977
|Aarhus university hospital NBG|
|Aarhus, Denmark, 8000|
|Principal Investigator:||Jens O Jørgnsen, Professor||University of Aarhus|